Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moseley

Showing results (361-370 of 376) with videos related to

Pageof 38
Sort By:
AJNR. American Journal of Neuroradiology|February 24, 2018
Brain Injury Lesion Imaging Using Preconditioned Quantitative Susceptibility Mapping without Skull StrippingS Soman, Z Liu, G Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2014
Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancerTarek M Abdel-Fatah, Graham Ball, Andrew H S Lee, et al.
Molecular Cancer Therapeutics|February 13, 2015
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast CancerArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Molecular Oncology|December 4, 2014
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M A Abdel-Fatah, Fiona K Middleton, Arvind Arora, et al.
Molecular Oncology|October 14, 2015
Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancerNouf Alsubhi, Fiona Middleton, Tarek M A Abdel-Fatah, et al.
Research Report (Health Effects Institute)|February 15, 2012
Pulmonary particulate matter and systemic microvascular dysfunctionTimothy R Nurkiewicz, Dale W Porter, Ann F Hubbs, et al.
The Lancet. Oncology|June 18, 2016
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysisTarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, et al.
Carcinogenesis|November 21, 2015
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancersArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Environmental Research|April 12, 2005
Indoor exposures to air pollutants and allergens in the homes of asthmatic children in inner-city BaltimorePatrick N Breysse, Timothy J Buckley, D'Ann Williams, et al.
Pageof 38

Showing results (361-370 of 376) with videos related to

Sort By:
Pageof 38
AJNR. American Journal of Neuroradiology|February 24, 2018
Brain Injury Lesion Imaging Using Preconditioned Quantitative Susceptibility Mapping without Skull StrippingS Soman, Z Liu, G Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2014
Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancerTarek M Abdel-Fatah, Graham Ball, Andrew H S Lee, et al.
Molecular Cancer Therapeutics|February 13, 2015
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast CancerArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Molecular Oncology|December 4, 2014
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M A Abdel-Fatah, Fiona K Middleton, Arvind Arora, et al.
Molecular Oncology|October 14, 2015
Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancerNouf Alsubhi, Fiona Middleton, Tarek M A Abdel-Fatah, et al.
Research Report (Health Effects Institute)|February 15, 2012
Pulmonary particulate matter and systemic microvascular dysfunctionTimothy R Nurkiewicz, Dale W Porter, Ann F Hubbs, et al.
The Lancet. Oncology|June 18, 2016
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysisTarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, et al.
Carcinogenesis|November 21, 2015
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancersArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Environmental Research|April 12, 2005
Indoor exposures to air pollutants and allergens in the homes of asthmatic children in inner-city BaltimorePatrick N Breysse, Timothy J Buckley, D'Ann Williams, et al.
Pageof 38